Lung Cancer Clinical Trials in Tampa, FL

Lung Cancer Clinical Trials in Tampa, FL

View the best 10 lung cancer medical studies in Tampa, Florida. Access promising new therapies by applying to a Tampa-based Lung Cancer clinical trial.

Trials in Tampa, Florida

Here are the top 10 medical studies for lung cancer in Tampa, Florida

Image of University of California San Francisco Medical Center in San Francisco, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial will test a new cancer treatment combining two drugs, one of which is a new experimental drug. The first part will determine how much of the new experimental drug is safe to use. The second part will test how well the combination of the two drugs works, how safe it is, and how well tolerated it is.
Image of Yuma Regional Medical Center Cancer Center in Yuma, United States.

Encorafenib +1 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new combination therapy for patients with a specific type of lung cancer. The trial will test how well the new therapy works and if it is safe.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Cisplatin +4 More

Alkylating agents

Recruiting2 awardsPhase 3
This trial is studying how well chemotherapy and radiation therapy work with or without atezolizumab in treating patients with limited stage small cell lung cancer.
Image of Children's Hospital of Alabama in Birmingham, United States.

Thoracotomy +1 More

Procedure

Recruiting2 awardsPhase 3
This trial compares the effect of open thoracic surgery to thoracoscopic surgery in treating patients with osteosarcoma that has spread to the lung.
Image of Cancer Care of North Florida in Lake City, United States.

NovoTTF-200T

Device

Recruiting1 awardPhase 2
This trial is testing a device that sends electric fields to the chest to treat lung cancer along with the drug pembrolizumab. The aim is to see if the combination can help people with lung cancer who haven't been treated before.
Image of Research Site in Bonita Springs, United States.

Olaparib

Recruiting0 awardsPhase 2
This trial is testing a combination of two drugs, Durvalumab and Olaparib, against using just Durvalumab alone. It targets adults with advanced lung cancer that cannot be treated with surgery or radiation and lacks certain genetic mutations. Durvalumab helps the immune system attack cancer, while Olaparib prevents cancer cells from repairing themselves. Durvalumab is a standard drug used after initial treatment in patients with advanced non-small cell lung cancer.
Image of University of Alabama at Birmingham in Birmingham, United States.

Zimberelimab +2 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial will study the safety and effectiveness of two different immunotherapy treatments for people with non-small cell lung cancer.
Image of Research Site in Chandler, United States.

Durvalumab +2 More

Checkpoint Inhibitor

Recruiting1 awardPhase 3
This trial is testing a new cancer treatment (durvalumab with SoC SBRT) against the current best treatment (placebo with SoC SBRT) for early stage non-small cell lung cancer.
Image of Alabama Oncology - Grandview in Birmingham, United States.

Sitravatinib +2 More

Tyrosine Kinase Inhibitor

Recruiting2 awardsPhase 3
This trial will compare the effectiveness of sitravatinib when given with nivolumab versus docetaxel in patients with advanced non-squamous NSCLC who have previously experienced disease progression after platinum-based chemotherapy and checkpoint inhibitor therapy.
Image of Hematology Oncology Associates of CNY, PC in East Syracuse, United States.

Adagrasib

Small Molecule Drug

Recruiting1 awardPhase 2
This trial tests a drug combo to treat advanced lung cancer with a genetic mutation.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.